<DOC>
	<DOCNO>NCT01652755</DOCNO>
	<brief_summary>To evaluate utility plasma cystatin C ( pCysC ) predictive diagnostic marker acute kidney injury ( AKI ) patient undergone cardiopulmonary bypass surgery .</brief_summary>
	<brief_title>Plasma Cystatin C Acute Kidney Injury</brief_title>
	<detailed_description>This prospective AKI observational study patient undergone cardiopulmonary bypass surgery . pCysC plasma creatine measure entry ICU.AKI define 50 % increase plasma creatine baseline.The predictive diagnostic performance pCysC assess area receiver operator characteristic curve ( AUC ) odds ratio ( OR ) .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Cystatins</mesh_term>
	<criteria>patient CPB admit ICU patient age &gt; 80 &lt; 18 year preexist renal dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>cystatin C , acute kidney injury ,</keyword>
</DOC>